Literature DB >> 17875433

Phenotype of the taurine transporter knockout mouse.

Ulrich Warskulat1, Birgit Heller-Stilb, Evelyn Oermann, Karl Zilles, Helmut Haas, Florian Lang, Dieter Häussinger.   

Abstract

This chapter reports present knowledge on the properties of mice with disrupted gene coding for the taurine transporter (taut-/- mice). Study of those mice unraveled some of the roles of taurine and its membrane transport for the development and maintenance of normal organ functions and morphology. When compared with wild-type controls, taut-/- mice have decreased taurine levels in skeletal and heart muscle by about 98%, in brain, kidney, plasma, and retina by 80 to 90%, and in liver by about 70%. taut-/- mice exhibit a lower body mass as well as a strongly reduced exercise capacity compared with taut+/- and wild-type mice. Furthermore, taut-/- mice show a variety of pathological features, for example, subtle derangement of renal osmoregulation, changes in neuroreceptor expression, and loss of long-term potentiation in the striatum, and they develop clinically relevant age-dependent disorders, for example, visual, auditory, and olfactory dysfunctions, unspecific hepatitis, and liver fibrosis. Taurine-deficient animal models such as acutely dietary-manipulated foxes and cats, pharmacologically induced taurine-deficient rats, and taurine transporter knockout mouse are powerful tools allowing identification of the mechanisms and complexities of diseases mediated by impaired taurine transport and taurine depletion (Chapman et al., 1993; Heller-Stilb et al., 2002; Huxtable, 1992; Lake, 1993; Moise et al., 1991; Novotny et al., 1991; Pion et al., 1987; Timbrell et al., 1995; Warskulat et al., 2004, 2006b). Taurine, which is the most abundant amino acid in many tissues, is normally found in intracellular concentrations of 10 to 70 mmol/kg in mammalian heart, brain, skeletal muscle, liver, and retina (Chapman et al., 1993; Green et al., 1991; Huxable, 1992; Timbrell et al., 1995). These high taurine levels are maintained by an ubiquitous expression of Na(+)-dependent taurine transporter (TAUT) in the plasma membrane (Burg, 1995; Kwon and Handler, 1995; Lang et al., 1998; Liu et al., 1992; Ramamoorthy et al., 1994; Schloss et al., 1994; Smith et al., 1992; Uchida et al., 1992; Vinnakota et al., 1997; Yancey et al., 1975). Taurine is not incorporated into proteins. It is involved in cell volume regulation, neuromodulation, antioxidant defense, protein stabilization, stress responses, and via formation of taurine-chloramine in immunomodulation (Chapman et al., 1993; Green et al., 1991; Huxtable, 1992; Timbrell et al., 1995). On the basis of its functions, taurine may protect cells against various types of injury (Chapman et al., 1993; Green et al., 1991; Huxtable, 1992; Kurz et al., 1998; Park et al., 1995; Stapleton et al., 1998; Timbrell et al., 1995; Welch and Brown, 1996; Wettstein and Häussinger, 1997). In order to examine the multiple taurine functions, murine models have several intrinsic advantages for in vivo research compared to other animal models, including lower cost, maintenance, and rapid reproduction rate. Further, experimental reagents for cellular and molecular studies are widely available for the mouse. In particular, mice can be easily genetically manipulated by making transgene and knockout mice. This chapter focuses on the phenotype of the TAUT-deficient murine model (taut-/-; Heller-Stilb et al., 2002), which may help researchers elucidate the diverse roles of taurine in development and maintenance of normal organ functions and morphology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875433     DOI: 10.1016/S0076-6879(07)28025-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  53 in total

Review 1.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Downregulation of hepatic betaine:homocysteine methyltransferase (BHMT) expression in taurine-deficient mice is reversed by taurine supplementation in vivo.

Authors:  Halina Jurkowska; Julie Niewiadomski; Lawrence L Hirschberger; Heather B Roman; Kevin M Mazor; Xiaojing Liu; Jason W Locasale; Eunkyue Park; Martha H Stipanuk
Journal:  Amino Acids       Date:  2015-10-20       Impact factor: 3.520

3.  Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.

Authors:  Jessica R Terrill; Gavin J Pinniger; Jamie A Graves; Miranda D Grounds; Peter G Arthur
Journal:  J Physiol       Date:  2016-01-18       Impact factor: 5.182

Review 4.  GABA(A) receptor and glycine receptor activation by paracrine/autocrine release of endogenous agonists: more than a simple communication pathway.

Authors:  Herve Le-Corronc; Jean-Michel Rigo; Pascal Branchereau; Pascal Legendre
Journal:  Mol Neurobiol       Date:  2011-05-06       Impact factor: 5.590

5.  Deletion of the γ-aminobutyric acid transporter 2 (GAT2 and SLC6A13) gene in mice leads to changes in liver and brain taurine contents.

Authors:  Yun Zhou; Silvia Holmseth; Caiying Guo; Bjørnar Hassel; Georg Höfner; Henrik S Huitfeldt; Klaus T Wanner; Niels C Danbolt
Journal:  J Biol Chem       Date:  2012-08-15       Impact factor: 5.157

6.  Role of glutamate decarboxylase-like protein 1 (GADL1) in taurine biosynthesis.

Authors:  Pingyang Liu; Xiaomei Ge; Haizhen Ding; Honglin Jiang; Bruce M Christensen; Jianyong Li
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

7.  Adult renal function is modified by perinatal taurine status in conscious male rats.

Authors:  Sanya Roysommuti; Pisamai Malila; Dusit Jirakulsomchok; J Michael Wyss
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 8.  Perinatal taurine exposure affects adult arterial pressure control.

Authors:  Sanya Roysommuti; J Michael Wyss
Journal:  Amino Acids       Date:  2012-10-16       Impact factor: 3.520

Review 9.  Sulfur as a signaling nutrient through hydrogen sulfide.

Authors:  Omer Kabil; Victor Vitvitsky; Ruma Banerjee
Journal:  Annu Rev Nutr       Date:  2014       Impact factor: 11.848

10.  Isolation of plasma membrane vesicles from mouse placenta at term and measurement of system A and system beta amino acid transporter activity.

Authors:  L C Kusinski; C J P Jones; P N Baker; C P Sibley; J D Glazier
Journal:  Placenta       Date:  2009-12-01       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.